{"id":19992,"date":"2025-05-02T06:20:19","date_gmt":"2025-05-02T06:20:19","guid":{"rendered":"https:\/\/cancercentertec100.com\/?p=19992"},"modified":"2025-05-28T18:19:07","modified_gmt":"2025-05-28T18:19:07","slug":"radiocirugia-en-hemangioblastomas","status":"publish","type":"post","link":"https:\/\/cancercentertec100.com\/en\/investigacion\/radiocirugia-en-hemangioblastomas\/","title":{"rendered":"RADIOCIRUG\u00cdA EN HEMANGIOBLASTOMAS"},"content":{"rendered":"<div id=\"cmsmasters_row_\" class=\"cmsmasters_row cmsmasters_color_scheme_default cmsmasters_row_top_default cmsmasters_row_bot_default cmsmasters_row_boxed\">\n<div class=\"cmsmasters_row_outer_parent\">\n<div class=\"cmsmasters_row_outer\">\n<div class=\"cmsmasters_row_inner\">\n<div class=\"cmsmasters_row_margin\">\n<div id=\"cmsmasters_column_\" class=\"cmsmasters_column one_first\">\n<div class=\"cmsmasters_column_inner\"><div class=\"cmsmasters_text\">\n<p class=\"has-color-4-color has-text-color\"><em><span style=\"color: #ff6600;\">Por: Dra. Yuliana Guiza Gonz\u00e1lez<br \/>Coordinadora de la Cl\u00ednica de Neurolog\u00eda de CCT100<\/span><\/em><\/p>\n<p><p>Hemangioblastomas son tumores benignos altamente vascularizados que corresponden 1- 3% de todos los tumores del sistema nervioso central.<\/p>\n<p>Seg\u00fan la clasificaci\u00f3n de WHO son tumores grado I y ocurren casi exclusivamente a nivel de sistema nervioso central y m\u00e1s poco frecuente en nervios perif\u00e9ricos.<\/p>\n<p>Estas lesiones pueden presentarse ya sea espor\u00e1dicamente en un 60-75% de los casos o secundario a enfermedad de VHL (Von Hippel Lindau) en un 20-40% de los casos.<\/p>\n<p>Los sintomas y signos asociados con estas lesiones son usualmente debido a efecto de masa o a estructuras anat\u00f3micas cercanas.<\/p>\n<p>En orden de frecuencia t\u00edpicamente ocurren en cerebelo en un 63%, medula espinal 32%, tallo 5% y en menor frecuencia en ra\u00edces lumbosacras.<\/p>\n<p>Las opciones terap\u00e9uticas actuales incluyen resecci\u00f3n microquir\u00fargica o radiocirug\u00eda.<\/p>\n<p><!-- \/wp:post-content --><\/p>\n<p><!-- wp:image {\"id\":18346,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} --><\/p>\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-19993 size-full\" src=\"https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio.jpg\" alt=\"\" width=\"1200\" height=\"1200\" srcset=\"https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio.jpg 1200w, https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio-300x300.jpg 300w, https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio-1024x1024.jpg 1024w, https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio-150x150.jpg 150w, https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio-768x768.jpg 768w, https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio-12x12.jpg 12w, https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio-65x65.jpg 65w, https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio-500x500.jpg 500w, https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio-580x580.jpg 580w, https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio-860x860.jpg 860w, https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/radio-1160x1160.jpg 1160w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/figure>\n<p>El tratamiento de primera l\u00ednea para los hemangioblastomas solitarios es la resecci\u00f3n microquir\u00fargica pero actualmente ha incrementado la opci\u00f3n de radiocirug\u00eda especialmente para lesiones con resecci\u00f3n incompleta , residuales o tumores recurrentes. As\u00ed como pacientes con comorbilidades que dificultan los procedimientos invasivos por el riesgo quir\u00fargico.<\/p>\n<p>Pacientes con enfermedad de VHL que tienen m\u00faltiples resecciones quir\u00fargicos previas pueden ser buenos candidatos para tratamiento con radiocirug\u00eda, ya que esta ofrece ventajas al no ser altamente invasiva y la capacidad para tratar tumores peque\u00f1os con menor morbilidad comparado con resecci\u00f3n quir\u00fargica, presentando una tasa de control tumoral de 92% a 3 a\u00f1os, 89% a 5 a\u00f1os y 79% a 10 a\u00f1os, as\u00ed como una tasa de supervivencia de 94% a 3 a\u00f1os, 90% a 5 a\u00f1os y 74% a 10 a\u00f1os con un perido de supervivencia global del 100% a 5 a\u00f1os.<\/p>\n<p>Si tienes alguna duda con este tratamiento cont\u00e1ctame a trav\u00e9s de Cancer Center Tec 100 al WhatsApp 442 333 9943 o al <a href=\"mailto:correo yguiza@cancercentertec100.com\" target=\"_blank\" rel=\"noopener\">correo yguiza@cancercentertec100.com<\/a><\/p>\n<p><span style=\"color: #333399;\"><strong>Referencias:<\/strong><\/span><br \/>Zare, A., Zare, A. Khaboushanm AS et al. Stereotactic radiosurgery in the management of central nervous system hemangioblasotmas: a systematic review and<br \/>meta-analysis. Neurosurg REV 48, 303 (2025).<br \/><a href=\"https:\/\/doi.org\/10.1007\/s10143-025-03454-9\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1007\/s10143-025-03454-9<\/a><br \/>Asthagiri AR et al (2010) Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Neuro Oncol 12 (1) :80-86.<br \/><a href=\"https:\/\/doi.org\/10.1093\/neuonc\/nop018\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1093\/neuonc\/nop018<\/a><\/p>\n<p><!-- \/wp:image --><\/p>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Hemangioblastomas son tumores benignos altamente vascularizados que corresponden 1- 3% de todos los tumores del sistema nervioso central.<\/p>\n<p>Seg\u00fan la clasificaci\u00f3n de WHO son tumores grado I y ocurren casi exclusivamente a nivel de sistema nervioso central y m\u00e1s poco frecuente en nervios perif\u00e9ricos.<\/p>","protected":false},"author":1,"featured_media":19994,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23,357,394,24],"tags":[398,391,395],"class_list":["post-19992","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-informacion-sobre-el-cancer","category-investigacion","category-radiocirugia","category-tratamiento","tag-hemangioblastomas","tag-radiocirugia","tag-tratamiento-contra-el-cancer"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RADIOCIRUG\u00cdA EN HEMANGIOBLASTOMAS<\/title>\n<meta name=\"description\" content=\"Hemangioblastomas son tumores benignos altamente vascularizados que corresponden 1- 3% de todos los tumores del sistema nervioso central. Seg\u00fan la clasificaci\u00f3n de WHO son tumores grado I y ocurren casi exclusivamente a nivel de sistema nervioso central y m\u00e1s poco frecuente en nervios perif\u00e9ricos.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cancercentertec100.com\/en\/investigacion\/radiocirugia-en-hemangioblastomas\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RADIOCIRUG\u00cdA EN HEMANGIOBLASTOMAS\" \/>\n<meta property=\"og:description\" content=\"Hemangioblastomas son tumores benignos altamente vascularizados que corresponden 1- 3% de todos los tumores del sistema nervioso central. Seg\u00fan la clasificaci\u00f3n de WHO son tumores grado I y ocurren casi exclusivamente a nivel de sistema nervioso central y m\u00e1s poco frecuente en nervios perif\u00e9ricos.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cancercentertec100.com\/en\/investigacion\/radiocirugia-en-hemangioblastomas\/\" \/>\n<meta property=\"og:site_name\" content=\"CANCER CENTER TEC 100\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CancerCenterTec100\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-02T06:20:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-28T18:19:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/yuliana.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"544\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/#\\\/schema\\\/person\\\/65e5d4a5cc0d9aef524b8c13b22c0cf3\"},\"headline\":\"RADIOCIRUG\u00cdA EN HEMANGIOBLASTOMAS\",\"datePublished\":\"2025-05-02T06:20:19+00:00\",\"dateModified\":\"2025-05-28T18:19:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/\"},\"wordCount\":388,\"publisher\":{\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cancercentertec100.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/yuliana.jpg\",\"keywords\":[\"HEMANGIOBLASTOMAS\",\"radiocirug\u00eda\",\"tratamiento contra el c\u00e1ncer\"],\"articleSection\":[\"Informaci\u00f3n sobre el c\u00e1ncer\",\"Investigaci\u00f3n\",\"Radiocirug\u00eda\",\"Tratamiento\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/\",\"url\":\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/\",\"name\":\"RADIOCIRUG\u00cdA EN HEMANGIOBLASTOMAS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cancercentertec100.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/yuliana.jpg\",\"datePublished\":\"2025-05-02T06:20:19+00:00\",\"dateModified\":\"2025-05-28T18:19:07+00:00\",\"description\":\"Hemangioblastomas son tumores benignos altamente vascularizados que corresponden 1- 3% de todos los tumores del sistema nervioso central. Seg\u00fan la clasificaci\u00f3n de WHO son tumores grado I y ocurren casi exclusivamente a nivel de sistema nervioso central y m\u00e1s poco frecuente en nervios perif\u00e9ricos.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cancercentertec100.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/yuliana.jpg\",\"contentUrl\":\"https:\\\/\\\/cancercentertec100.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/yuliana.jpg\",\"width\":1200,\"height\":544},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/investigacion\\\/radiocirugia-en-hemangioblastomas\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cancercentertec100.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RADIOCIRUG\u00cdA EN HEMANGIOBLASTOMAS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/#website\",\"url\":\"https:\\\/\\\/cancercentertec100.com\\\/\",\"name\":\"CANCER CENTER TEC 100\",\"description\":\"Tu mejor opci\u00f3n para el tratamiento del c\u00e1ncer.\",\"publisher\":{\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cancercentertec100.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/#organization\",\"name\":\"CANCER CENTER TEC 100\",\"url\":\"https:\\\/\\\/cancercentertec100.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cancercentertec100.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/LOGO-CCT-01.png\",\"contentUrl\":\"https:\\\/\\\/cancercentertec100.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/LOGO-CCT-01.png\",\"width\":3703,\"height\":2062,\"caption\":\"CANCER CENTER TEC 100\"},\"image\":{\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CancerCenterTec100\",\"https:\\\/\\\/www.instagram.com\\\/cancercentertec100\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCYadf0oSR1BKrlNYqWq2PvQ\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/cancer-center-tec-100\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cancercentertec100.com\\\/#\\\/schema\\\/person\\\/65e5d4a5cc0d9aef524b8c13b22c0cf3\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4b2ecb6fc814045247978b37ad70e11d15b136ab293888c8ffe9724aeec50b1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4b2ecb6fc814045247978b37ad70e11d15b136ab293888c8ffe9724aeec50b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4b2ecb6fc814045247978b37ad70e11d15b136ab293888c8ffe9724aeec50b1?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/cancercentertec100.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RADIOCIRUG\u00cdA EN HEMANGIOBLASTOMAS","description":"Hemangioblastomas son tumores benignos altamente vascularizados que corresponden 1- 3% de todos los tumores del sistema nervioso central. Seg\u00fan la clasificaci\u00f3n de WHO son tumores grado I y ocurren casi exclusivamente a nivel de sistema nervioso central y m\u00e1s poco frecuente en nervios perif\u00e9ricos.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cancercentertec100.com\/en\/investigacion\/radiocirugia-en-hemangioblastomas\/","og_locale":"en_US","og_type":"article","og_title":"RADIOCIRUG\u00cdA EN HEMANGIOBLASTOMAS","og_description":"Hemangioblastomas son tumores benignos altamente vascularizados que corresponden 1- 3% de todos los tumores del sistema nervioso central. Seg\u00fan la clasificaci\u00f3n de WHO son tumores grado I y ocurren casi exclusivamente a nivel de sistema nervioso central y m\u00e1s poco frecuente en nervios perif\u00e9ricos.","og_url":"https:\/\/cancercentertec100.com\/en\/investigacion\/radiocirugia-en-hemangioblastomas\/","og_site_name":"CANCER CENTER TEC 100","article_publisher":"https:\/\/www.facebook.com\/CancerCenterTec100","article_published_time":"2025-05-02T06:20:19+00:00","article_modified_time":"2025-05-28T18:19:07+00:00","og_image":[{"width":1200,"height":544,"url":"https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/yuliana.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/#article","isPartOf":{"@id":"https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/"},"author":{"name":"admin","@id":"https:\/\/cancercentertec100.com\/#\/schema\/person\/65e5d4a5cc0d9aef524b8c13b22c0cf3"},"headline":"RADIOCIRUG\u00cdA EN HEMANGIOBLASTOMAS","datePublished":"2025-05-02T06:20:19+00:00","dateModified":"2025-05-28T18:19:07+00:00","mainEntityOfPage":{"@id":"https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/"},"wordCount":388,"publisher":{"@id":"https:\/\/cancercentertec100.com\/#organization"},"image":{"@id":"https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/#primaryimage"},"thumbnailUrl":"https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/yuliana.jpg","keywords":["HEMANGIOBLASTOMAS","radiocirug\u00eda","tratamiento contra el c\u00e1ncer"],"articleSection":["Informaci\u00f3n sobre el c\u00e1ncer","Investigaci\u00f3n","Radiocirug\u00eda","Tratamiento"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/","url":"https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/","name":"RADIOCIRUG\u00cdA EN HEMANGIOBLASTOMAS","isPartOf":{"@id":"https:\/\/cancercentertec100.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/#primaryimage"},"image":{"@id":"https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/#primaryimage"},"thumbnailUrl":"https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/yuliana.jpg","datePublished":"2025-05-02T06:20:19+00:00","dateModified":"2025-05-28T18:19:07+00:00","description":"Hemangioblastomas son tumores benignos altamente vascularizados que corresponden 1- 3% de todos los tumores del sistema nervioso central. Seg\u00fan la clasificaci\u00f3n de WHO son tumores grado I y ocurren casi exclusivamente a nivel de sistema nervioso central y m\u00e1s poco frecuente en nervios perif\u00e9ricos.","breadcrumb":{"@id":"https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/#primaryimage","url":"https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/yuliana.jpg","contentUrl":"https:\/\/cancercentertec100.com\/wp-content\/uploads\/2025\/05\/yuliana.jpg","width":1200,"height":544},{"@type":"BreadcrumbList","@id":"https:\/\/cancercentertec100.com\/investigacion\/radiocirugia-en-hemangioblastomas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cancercentertec100.com\/"},{"@type":"ListItem","position":2,"name":"RADIOCIRUG\u00cdA EN HEMANGIOBLASTOMAS"}]},{"@type":"WebSite","@id":"https:\/\/cancercentertec100.com\/#website","url":"https:\/\/cancercentertec100.com\/","name":"CANCER CENTER TEC 100","description":"Your best option for cancer treatment","publisher":{"@id":"https:\/\/cancercentertec100.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cancercentertec100.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cancercentertec100.com\/#organization","name":"CANCER CENTER TEC 100","url":"https:\/\/cancercentertec100.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cancercentertec100.com\/#\/schema\/logo\/image\/","url":"https:\/\/cancercentertec100.com\/wp-content\/uploads\/2024\/03\/LOGO-CCT-01.png","contentUrl":"https:\/\/cancercentertec100.com\/wp-content\/uploads\/2024\/03\/LOGO-CCT-01.png","width":3703,"height":2062,"caption":"CANCER CENTER TEC 100"},"image":{"@id":"https:\/\/cancercentertec100.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CancerCenterTec100","https:\/\/www.instagram.com\/cancercentertec100\/","https:\/\/www.youtube.com\/channel\/UCYadf0oSR1BKrlNYqWq2PvQ","https:\/\/www.linkedin.com\/company\/cancer-center-tec-100"]},{"@type":"Person","@id":"https:\/\/cancercentertec100.com\/#\/schema\/person\/65e5d4a5cc0d9aef524b8c13b22c0cf3","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a4b2ecb6fc814045247978b37ad70e11d15b136ab293888c8ffe9724aeec50b1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a4b2ecb6fc814045247978b37ad70e11d15b136ab293888c8ffe9724aeec50b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a4b2ecb6fc814045247978b37ad70e11d15b136ab293888c8ffe9724aeec50b1?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/cancercentertec100.com"]}]}},"_links":{"self":[{"href":"https:\/\/cancercentertec100.com\/en\/wp-json\/wp\/v2\/posts\/19992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancercentertec100.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cancercentertec100.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cancercentertec100.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cancercentertec100.com\/en\/wp-json\/wp\/v2\/comments?post=19992"}],"version-history":[{"count":3,"href":"https:\/\/cancercentertec100.com\/en\/wp-json\/wp\/v2\/posts\/19992\/revisions"}],"predecessor-version":[{"id":20051,"href":"https:\/\/cancercentertec100.com\/en\/wp-json\/wp\/v2\/posts\/19992\/revisions\/20051"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cancercentertec100.com\/en\/wp-json\/wp\/v2\/media\/19994"}],"wp:attachment":[{"href":"https:\/\/cancercentertec100.com\/en\/wp-json\/wp\/v2\/media?parent=19992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cancercentertec100.com\/en\/wp-json\/wp\/v2\/categories?post=19992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cancercentertec100.com\/en\/wp-json\/wp\/v2\/tags?post=19992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}